Alan M. Solinger

2.8k citations
41 papers · 2.3k · 1 hit paper · h-index 22

Impact in

    • Spondyloarthritis Studies and Treatments
    • Rheumatoid Arthritis Research and Therapies
    • Systemic Lupus Erythematosus Research
  • Immunology top 5%
    • Psoriasis: Treatment and Pathogenesis

Papers in

    • Spondyloarthritis Studies and Treatments 7
    • Rheumatoid Arthritis Research and Therapies 4
    • Systemic Lupus Erythematosus Research 4
    • HIV Research and Treatment 5

Alan M. Solinger

39 papers receiving 2.2k citations

Alan M. Solinger's Hit Papers

Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study 2018 · 318 citations
3180+2+5Years since publication100200300

Peers

Alan M. Solinger
Comparison fields: 5 of 82
  • Rheumatology 622
  • Immunology 537
  • Ophthalmology 166
  • Emergency Medicine 77
  • Virology 41
Replace F Danon with:
F Danon France
Peter B. Dent Canada
Marino Paroli Italy
Juergen Schmitz Germany
Myriam Labalette France
Mathieu Gerfaud‐Valentin France
Tomonori Ishii Japan
R. John Looney United States
Lilian Ágnes Varga Hungary
P. A. Dyer United Kingdom
Alan M. Solinger relative to F Danon France F Danon's profile →
Citations per field
00.5×2×4×6×8×9.8×
F Danon · 1×
Citations per year

Countries citing papers authored by Alan M. Solinger

Since Specialization
Citations

This map shows the geographic impact of Alan M. Solinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan M. Solinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan M. Solinger more than expected).

Fields of papers citing papers by Alan M. Solinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan M. Solinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan M. Solinger. The network helps show where Alan M. Solinger may publish in the future.

Co-authors

The 25 scholars most cited alongside Alan M. Solinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alan M. Solinger Line = papers co-authored together Alan M. Solinger links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study
Hit paper breakdown →
2018318
2 2010298
3 2012249
4 2015216
5 2011198
6 2005127
7 199091
8 198188
9 198174
10 200469
11 201154
12 199246
13 198042
14
Human immunodeficiency virus infection is not associated with Reiter's syndrome. Data from three large cohort studies.
199239
15
Drug-related lupus. Clinical and etiologic considerations.
198836
16 198833
17
Concomitant medication use in a large, international, multicenter, placebo controlled trial of anakinra, a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis.
200433
18 198731
19 198931
20
Rheumatic diseases and AIDS--is the association real?
199329

About Alan M. Solinger

Alan M. Solinger is a scholar working on Rheumatology, Virology, Immunology, Ophthalmology and Emergency Medicine, having authored 41 papers that have together received 2.3k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (7 papers), HIV Research and Treatment (5 papers), T-cell and B-cell Immunology (5 papers), Rheumatoid Arthritis Research and Therapies (4 papers), Systemic Lupus Erythematosus Research (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), Multiple Myeloma Research and Treatments (2 papers) and Diabetes Treatment and Management (2 papers). The work is most often cited by research in Rheumatology (622 citations), Immunology (537 citations), Ophthalmology (166 citations), Emergency Medicine (77 citations) and Virology (41 citations). Alan M. Solinger has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Charles Anthony Dinarello, Suzanne L. Bowyer, Daniel J. Lovell, Stella Aslanyan, Steven J. Padula, Paul R. Scholl, Sudha Visvanathan, E V Hess, Marc Yves Donath and Cornelia Keller. Their work appears in journals such as Rheumatic Disease Clinics of North America, Blood, Diabetes Care, Annals of the Rheumatic Diseases and Advances in experimental medicine and biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact